Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
This study has been completed.
Information provided by:
NIH AIDS Clinical Trials Information Service
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: September 1989
To provide ganciclovir on a compassionate use basis to immunocompromised patients with serious cytomegalovirus (CMV) infections and to study safety and efficacy in this patient population.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by NIH AIDS Clinical Trials Information Service:
Contacts and Locations